Hantz Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Hantz Financial Services's ALNY Position: Q3 2026 in Review
Hantz Financial Services reduced its Alnylam Pharmaceuticals (ALNY) stake by 54% in Q3 2026, selling an estimated $2.17M and leaving 7,345 shares worth $1.81M. The position accounts for 0.02% of the portfolio, ranked #364.
Hantz Financial Services first reported a position in ALNY in Q2 2025 and has held it in 6 quarters since. The position peaked at $6M in Q3 2025. 633 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Hantz Financial Services held 7,345 shares of Alnylam Pharmaceuticals worth $1.81M as of Q3 2026.
- Hantz Financial Services sold 8,538 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $2.17M.
- Alnylam Pharmaceuticals made up 0.02% of Hantz Financial Services's portfolio in Q3 2026, its #364 holding.
- Hantz Financial Services first reported a position in Alnylam Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
- Hantz Financial Services's Alnylam Pharmaceuticals position peaked at $6M in Q3 2025.
- 633 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Hantz Financial Services's 13F filing for Q3 2026, filed 9 Nov 2026.